Gene · 708
Papers2,456
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 2,456
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic nucleoplasmic and nucleolar localization of mammalian RNase H1 in response to RNAP I transcriptional R-loops. | Nucleic Acids Res | 2017 | 28977560 | PubTator, text mining | PubMed |
| Biallelic C1QBP Mutations Cause Severe Neonatal-, Childhood-, or Later-Onset Cardiomyopathy Associated with Combined Respiratory-Chain Deficiencies. | Am J Hum Genet | 2017 | 28942965 | Swiss-Prot, curated | PubMed |
| Antisense oligonucleotides targeting translation inhibitory elements in 5' UTRs can selectively increase protein levels. | Nucleic Acids Res | 2017 | 28934489 | PubTator, text mining | PubMed |
| Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection. | Vaccines (Basel) | 2017 | 28862649 | PubTator, text mining | PubMed |
| The immune response to secondary necrotic cells. | Apoptosis | 2017 | 28861714 | PubTator, text mining | PubMed |
| Development of duplex PCR for differential detection of goatpox and sheeppox viruses. | BMC Vet Res | 2017 | 28859636 | PubTator, text mining | PubMed |
| Collagen Complexity Spatially Defines Microregions of Total Tissue Pressure in Pancreatic Cancer. | Sci Rep | 2017 | 28855644 | PubTator, text mining | PubMed |
| Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II. | Diabetes Care | 2017 | 28851702 | PubTator, text mining | PubMed |
| Identification of novel biomarkers to monitor β-cell function and enable early detection of type 2 diabetes risk. | PLoS One | 2017 | 28846711 | PubTator, text mining | PubMed |
| RAP80 binds p32 to preserve the functional integrity of mitochondria. | Biochem Biophys Res Commun | 2017 | 28842250 | PubTator, text mining | PubMed |
| Engineered endothelium provides angiogenic and paracrine stimulus to grafted human ovarian tissue. | Sci Rep | 2017 | 28811567 | PubTator, text mining | PubMed |
| Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. | Sci Rep | 2017 | 28811496 | PubTator, text mining | PubMed |
| lncRNAs in development and disease: from functions to mechanisms. | Open Biol | 2017 | 28747406 | PubTator, text mining | PubMed |
| Gene-wide Association Study Reveals RNF122 Ubiquitin Ligase as a Novel Susceptibility Gene for Attention Deficit Hyperactivity Disorder. | Sci Rep | 2017 | 28710364 | PubTator, text mining | PubMed |
| MNRR1, a Biorganellar Regulator of Mitochondria. | Oxid Med Cell Longev | 2017 | 28685009 | PubTator, text mining | PubMed |
| Delivery of gene targeting siRNAs to breast cancer cells using a multifunctional peptide complex that promotes both targeted delivery and endosomal release. | PLoS One | 2017 | 28666009 | PubTator, text mining | PubMed |
| Correction for Fogal et al., "Mitochondrial p32 Protein Is a Critical Regulator of Tumor Metabolism via Maintenance of Oxidative Phosphorylation". | Mol Cell Biol | 2017 | 28663271 | PubTator, text mining | PubMed |
| RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus. | Mol Ther | 2017 | 28663102 | PubTator, text mining | PubMed |
| Potential of Central, Eastern and Western Africa Medicinal Plants for Cancer Therapy: Spotlight on Resistant Cells and Molecular Targets. | Front Pharmacol | 2017 | 28626426 | PubTator, text mining | PubMed |
| Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling. | Int J Cancer | 2017 | 28608366 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/708/papers?page=58